Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Grunenthal

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Grunenthal's 2013 immunology sales performance.

AZ divests European rights for cholesterol med Crestor to Grünenthal

AZ divests European rights for cholesterol med Crestor to Grünenthal

It will also continue to manufacture and supply Crestor to Grünenthal during the transition period. ... AZ. “Grünenthal previously acquired the rights to several established AstraZeneca medicines and is well placed to ensure continued access to

Big Pharma, Little Pharma

Big Pharma, Little Pharma to dominate a particular ecological niche. Think penguins or wildebeest. We see other firms attempting similar evolution, such as Grunenthal with pain management and Ferring with women’s health.

Gilead and ViiV among winners at PM Society Digital Awards

Gilead and ViiV among winners at PM Society Digital Awards Allergan, Glenmark, Grunenthal, Merck Serono, MSD and Novartis and all won Gold as well. .

Europe's public-private alliance targets pain management

Europe's public-private alliance targets pain management an effort led by Winfried Meissner of the University of Jena and Hiltrud Liedgens of drugmaker Grünenthal.

Pharma's first 'performance marketing' agency launched

Pharma's first 'performance marketing' agency launched Prior to that he spent a decade in pharma, first at Sanofi and then Grünenthal, rising to senior marketing manager at the latter before moving agency-side.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...